Published
Comparison and Evaluation of Marketed Tablet of Spironolactone
Published in March 2024 Issue 03 (Vol. 12, Issue 3, 2024)
Abstract
ABSTRACTThe primary goal is to evaluate and compare the quality standards of branded and generic forms of the antihypertensive medication (Spironolactone). The drugs are evaluated and results showed that branded and generic meet the pharmacopoeial specifications. According to pharmacopeia, every tablet passed the test for weight fluctuation, hardness, friability, disintegration and dissolution. Thus, we can say that antihypertensive medications are equal. Keywords: Spironolactone; Physicochemical test; In-vitro studies.
Authors (2)
Samyuktha.S¹
View all publications →Balamurugan K
View all publications →Download Article
Best for printing and citation
File size: 0.0 MB
Format: PDF
Article Information
Published in:
March 2024 Issue 03 (Vol. 12, Issue 3, 2024)Article Impact
Views:1,828
Downloads:2,165
scite_
Smart Citations
0Citing Publications
0Supporting
0Mentioning
0Contrasting
View Citations
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
How to Cite
Samyuktha.S¹ & K (2024). Comparison and Evaluation of Marketed Tablet of Spironolactone. American Journal of Pharmacy and Health Research, 12(3), xx-xx. DOI:https://doi.org/10.5281/zenodo.13833114
Article Actions
More by These Authors
Studies on Design and Development of Mouth Dissolving Film of Desloratadine
2018 • Vol. 6, Issue 3
Read more →